trial · primary record
Entecavell ODT
Hepatitis B Virus
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 82 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Change in eGFR at week 48 |
| Registry ID | NCT07267208 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:18.121Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07267208
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.